NCT02137915

Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

Long-Term Follow-up Study of the Phase I/II Safety and Preliminary Efficacy of Human Central Nervous System Stem Cells (HuCNS-SC) Subretinal Transplantation in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 8 (actual)
• Sponsor: StemCells, Inc. · Industry
• Sex: All
• Age: 51 Years
• Healthy volunteers: Not accepted

Summary

This study is being done to determine the long-term safety and possible benefits of transplanted Human Central Nervous System Stem Cells (HuCNS-SC) for patients with Geographic Atrophy of Age-Related Macular Degeneration. This long-term follow-up study is limited to those individuals who received a transplant of HuCNS-SC cells into one of their eyes as part of the CL-N01-AMD study. No additional study product will be given in this 4-year long-term follow-up study.

Conditions

• Age-Related Macular Degeneration
• Geographic Atrophy

Interventions

Type	Name	Description
BIOLOGICAL	Human Central Nervous System Stem Cells

Timeline

• Start date: 2014-04-01
• Primary completion: 2016-05-01
• Completion: 2016-05-01
• First posted: 2014-05-14
• Last updated: 2016-06-02

Locations

1 site across 1 country: United States